• 已选条件：
  • × CDK4/6 inhibitors
 全选  【符合条件的数据共：22条】

1 Cost-Effectiveness Analysis of Abemaciclib Plus Fulvestrant in the Second-Line Treatment of Women With HR+/HER2– Advanced or Metastatic Breast Cancer: A US Payer Perspective [期刊论文]

来源：Frontiers in Medicine , 2021

作者:Pingyu Chen;Yingdan Cao;Xin Guan;等

关键词:cost-effectiveness;abemaciclib;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

2 CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience [期刊论文]

来源：Medical Sciences , 2021

作者:Angeliki Andrikopoulou;Michalis Liontos;Anastasios Kyriazoglou;等

关键词:CDK4/6 inhibitors;arthralgia;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

3 Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib [期刊论文]

来源：Breast Cancer: Targets and Therapy , 2017

作者:

关键词:cell cycle*;cyclin-dependent kinase 4/6;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

4 CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis [期刊论文]

来源：ESMO Open , 2021

作者:E. Agostinetto;L. Vian;R. Caparica;等

关键词:breast cancer;HR-positive;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

5 Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials [期刊论文]

来源：ESMO Open , 2021

作者:E. Munzone;E. Pagan;V. Bagnardi;等

关键词:metastatic breast cancer;ER-positive/HER2-negative;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

6 Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib [期刊论文]

来源：Frontiers in Pharmacology , 2023

作者:Zhimin Zhu, Qiongni Zhu

关键词:targeted therapy;CDK4/6 inhibitors;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]